What is Wedbush’s Forecast for OVID FY2029 Earnings?
Wedbush issued their FY2029 earnings estimates for Ovid Therapeutics in a note issued to investors on Wednesday, March 12th.
Apple sees bullish views at Wedbush on product and AI driven services growth ahead
Wedbush maintained its Outperform rating on Apple (NASDAQ:AAPL) noting that the company's next stage of product and AI driven ...
Wedbush Cuts RumbleOn (NASDAQ:RMBL) Price Target to $5.00
RumbleOn (NASDAQ:RMBL – Free Report) had its target price lowered by Wedbush from $5.50 to $5.00 in a research report report published on Wednesday,Benzinga reports. The firm currently has an ...